Skip to search formSkip to main contentSkip to account menu

Fendrix

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Hepatitis B Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Humoral and Cellular Responses to a Single Dose of Fendrix in Renal Transplant Recipients with Non‐response to Previous Hepatitis B Vaccination
Approximately 70% of kidney transplant recipients are non‐responders to conventional hepatitis B virus (HBV) vaccines. We… 
2017
2017
Immune Responses of Mice Immunized with HBsAg Formulated in Naloxone/Alum Mixture: Comparison to Fendrix Vaccine
Background: Hepatitis B virus (HBV) can cause cirrhosis of the liver and hepatocellular carcinoma. Due to the lack of sufficient… 
2015
2015
Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
ABSTRACT Subunit vaccines based on the herpes simplex virus 2 (HSV-2) glycoprotein D (gD-2) have been the major focus of HSV-2… 
2014
2014
Determinants of response to repeat hepatitis B vaccination in HIV-infected prior non-responders.
2012
2012
Efficacy of a hepatitis B vaccination schedule with two cycles of four double doses of conventional vaccine and four doses of adjuvanted vaccine in chronic kidney disease patients evaluated for renal…
2011
2011
Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepatitis B vaccine: preliminary data.
AIM Most chronic uremic patients undergoing dialysis show a diminished antibody response to anti-hepatitis B vaccination (anti… 
Review
2008
Review
2008
Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients
Background: High susceptibility to infections including the hepatitis B virus (HBV) causes increased morbidity and mortality in… 
Review
2008
Review
2008
Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients.
BACKGROUND High susceptibility to infections including the hepatitis B virus (HBV) causes increased morbidity and mortality in… 
Highly Cited
2006
Highly Cited
2006
TLR4 agonists as immunomodulatory agents
Monophosphoryl lipid A (MPL®) is a potent vaccine adjuvant derived from Salmonella minnesota that was recently licensed in Europe… 
Highly Cited
2005
Highly Cited
2005
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients.
BACKGROUND Due to their impaired immune system, patients with renal insufficiency have a suboptimal response to hepatitis B (HB… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)